A quest to detect lung cancer — before it’s too late
Early in his career, Sam Hanash, M.D., Ph.D., faced the difficult task of telling the families and loved ones of late-stage cancer patients that they had only a short time to live. Because cancers such as lung grow quietly and aren’t detected until they’ve become advanced and spread to other parts of the body, doctors don’t detect the disease until it’s too late.
Hanash, a professor of Clinical Cancer Prevention, resolved to find...
MD Anderson named the top cancer hospital
MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.
Can this protein prevent or kill breast cancer tumors?
Every parent knows the maxim “feed a cold, starve a fever.” In cancer, however, exactly how to feed or starve a tumor has not been easy to...
Similarities between embryos and breast tumors identified
Breast tumors may have something in common with embryos … at least in mice, say researchers at MD Anderson Cancer Center.
A study led by Sendurai Mani, Ph.D., associate professor of Translational Molecular Pathology at MD Anderson, and Jeffrey Chang, Ph.D., assistant professor of Integrative Biology at The University of Texas Health Science Center at Houston, found that tumors resembling six-day-old mouse embryos are more prone...
MD Anderson will be site of Genome Characterization Center
MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer...
Turning the immune system against metastatic breast cancer
Although the cure rate for breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to control...
Many colorectal cancer cases among certain group are hereditary
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at MD Anderson...
Reducing risk while leaving menopause for later
Women with BRCA1 mutations have a 39% risk of ovarian cancer compared to the general population’s risk of 1.3%, while women with BRCA2 mutations...